Article
Author(s):
ICYMI, this week we had stories about evolving research and treatment options for plaque psoriasis, the role of dermatology PAs, tazarotene lotion for acne, and more.
Roger Ceilley, MD, reviewed his best tips for ensuring the best patient outcomes after surgical procedures at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.
In this episode, Jonathan Silverberg, MD, PhD, MPH, discusses the effects of environmental pollutants on atopic dermatitis, including flares, severity, and recommendations for avoiding these pollutants when possible.
A poster presentation from the Fall Clinical Dermatology Conference for PAs and NPs evaluated the safety and efficacy of tazarotene for acne patients with skin of color.
Level Ex, Inc.'s Top Derm is changing the way dermatologists learn about skin conditions—all through a cell phone screen.
Despite this, researchers found that Hsp70 plasma levels did not correlate with the extent of disease.
Joan Merrill, MD, explained the study's efficacy and safety outcomes and looks forward to phase 3 trials ahead.
If you weren’t able to attend Fall Clinical for PAs and NPs or want to review our latest coverage and interviews, our full recap has you covered.
More than $600,000 have been donated to raise awareness of melanoma with the #Stickit2Melanoma pledge.
Jennifer Orozco, DMSc, PA-C, DFAAPA, oversees the American Academy of Physician Associates and advocates for the role of PAs.
The new technique analyzes RNA from infant sebum samples.
The current dermatology pipeline includes a wide range of medication classes, from Janus kinase (JAK) inhibitors to tumor necrosis factor inhibitors, to phototherapeutics.
Four dermatologists from across the country discuss the widened armamentarium of AD treatments in a recent Around the Practice series.
Click here to answer this week's poll.
Researchers also identified 50% improvement in appearance with larger spot laser use.
Advanced Dermatology and Cosmetic Surgery utilized a streamlining tool to increase their net profit by $9.5 million in 1 year.
The research delving into skin conditions affecting patients with skin of color, patients in the LGBTQIA+ community, and patients requiring multidisciplinary treatment continues to grow.
Five expert dermatology clinicians discuss the changing landscape of plaque psoriasis treatments and research for adult patients.
Zoe Diana Draelos, MD, editor in chief of Dermatology Times, reviews dermatology's role in pop culture and social media trends: "Popular skin culture has nothing on us but a new vocabulary."
In a murine model, application of PALA in topical fashion led to reductions in tumor grades and numbers.
Researchers tested bovine sialogylcoproteins on human dermal fibroblasts.
Lauren Miller, MPAS, PA-C, and Tj Chao, MPAS, PA-C, review how they discuss available treatment options for their plaque psoriasis patients in a recent DermView series.